PPARA and hydrops fetalis: Because thiazolidinediones, which are considered a contraindication for patients with HF [21,23], are PPAR-χ agonists, they can activate the uptake and oxidation of FAs (simultaneously with glucose) and further enforce FA uptake and oxidation in a failing heart.